HIV &
Incarceration

By the numbers

BJS estimated 12,460 people with known HIV in state and federal prison custody at year-end 2023, compared with 12,200 in 2022. These are prison data, not a combined prison-and-jail count. Comparisons with community prevalence require matching years and denominators.12

Why HIV rates are higher in correctional settings

The elevated HIV prevalence in correctional facilities is not primarily a product of what happens inside — it is a product of who is incarcerated. The U.S. criminal justice system disproportionately incarcerates the same communities that are disproportionately affected by HIV: Black and Latino men, people who inject drugs, people who have engaged in sex work, and people experiencing poverty and housing instability.

When you concentrate people from high-HIV-prevalence communities into a single setting, you concentrate HIV. This is not a moral statement about incarcerated people — it is a structural observation about who is caught in the criminal justice system and why.

The role of drug policy

The war on drugs has driven mass incarceration of people who inject drugs — the population that faces HIV transmission risk through needle sharing. Incarcerating rather than treating people with substance use disorders removes them from harm reduction services (syringe programs, naloxone, MAT) and concentrates HIV risk without addressing its roots.

The role of sex work criminalization

Criminalization of sex work drives repeated incarceration of people — disproportionately women and transgender women of color — who face elevated HIV risk. Each incarceration cycle disrupts HIV care, treatment, and prevention for some of the most vulnerable people in the epidemic.

HIV inside correctional facilities

Sexual transmission

A 2020 California implementation study described limited condom availability in U.S. correctional systems at that time. California’s 2015–2016 rollout demonstrated a feasible, low-cost program with no serious condom-related incidents reported. Its historical program count should not be read as a current national inventory.34

Injection drug use

Sharing injection equipment can transmit HIV and other bloodborne infections. Access to prevention and substance-use treatment varies by facility; this article does not establish a current inventory of prison syringe programs.

Tattooing

Tattooing with equipment contaminated by another person’s blood can create a bloodborne infection risk. Avoid shared, unsterilized needles or ink; the risk mechanism does not prove that a particular facility has had tattoo-related HIV transmission.

Sexual violence

Sexual violence in correctional settings is a real and documented problem. The Prison Rape Elimination Act (PREA) was passed in 2003 specifically to address this — but implementation has been inconsistent, and survivors often face barriers to accessing PEP after assault. HIV transmission through sexual violence in correctional settings is a public health and human rights issue that rarely receives adequate attention.

Testing at intake: what CDC recommends, what happens in practice

The CDC recommends that correctional and detention facilities offer HIV screening on an opt-out basis — meaning people are tested unless they specifically decline — because prevalence in these settings is high enough to warrant it⁴. Opt-out testing dramatically increases the number of people who learn their status compared to opt-in models.

BJS reported opt-out intake testing in 29 of 50 reporting jurisdictions in 2023, and some form of HIV testing in all 50. The remaining systems used other approaches; it is incorrect to say they all tested only on request or did not test at all.1

HIV care gaps inside

ART access at intake

Booking, transfers, or formulary changes can disrupt ART. NIH advises minimizing interruptions because they can cause viral rebound, immune decline, and resistance. The timing varies; a fixed 10–14-day threshold is not a safe grace period.^[15]5

Quality of care inside

The Supreme Court’s Estelle v. Gamble decision established that deliberate indifference to prisoners’ serious medical needs violates the Eighth Amendment. Clinical concerns should be reported promptly through available medical and grievance channels; legal assistance may be needed when care remains denied. The legal analysis differs for some detained populations.6

PrEP access differs across correctional facilities. CDC recommends discussing PrEP with people who may have HIV exposures and arranging community linkage before release; ask the medical team what is available.

Mental health and HIV

Incarcerated people living with HIV face compounded mental health burdens: the psychological impact of incarceration, trauma (including from sexual violence), stigma about HIV status inside facilities (which can be severe and occasionally violent), and the stress of navigating both HIV care and legal situations at the same time. Mental health services inside are often inadequate for the general population, let alone the complex needs of people living with HIV.

The re-entry crisis

Release can disrupt ART and follow-up. A systematic review found declines in HIV care outcomes after release, but it did not establish one universal risk window or rebound rate. U=U requires maintained viral suppression; arrange enough ART and a follow-up plan before release.75

Insurance and medication gaps

Since January 1, 2026, states must not terminate Medicaid eligibility solely because of incarceration. Eligibility or benefits may be suspended, and payment restrictions remain. Confirm enrollment, renewal requirements, and reactivation before release.^[16]

Housing instability

Unstable housing can complicate appointments, storage, and routines, but it does not make HIV treatment impossible. Ask for housing and care support together; do not wait for housing before contacting a clinic.

Loss of medical continuity

Medical records may not transfer smoothly from correctional facilities to community providers. HIV specialists in the community may have no history for a newly released patient. Resistance testing results, prior regimen history, and other clinical information can be lost in the transition.

Medicaid re-entry services: check current state and facility participation

CMS allows approved section 1115 demonstrations to cover certain services before release. The model includes case management, substance-use treatment, and a medication supply at release, but access depends on the state’s approval, implementation, eligible population, and participating facility.8

State approvals and implementation change. Use CMS’s current re-entry information and demonstration list to check the state and facility involved; an approved waiver does not mean every person already receives services.910

What a good HIV discharge plan looks like

HRSA Policy 18-02 permits coordinated transitional Ryan White services for eligible people nearing release, generally during a locally defined period of 180 days or fewer. This is not a universal 180-day limit on Ryan White care after release. A practical discharge plan should include:1112

• Enough ART to reach the community appointment. CDC recommends an adequate bridge supply; verify the quantity, regimen, and refill route before release.
• A booked community HIV appointment early enough to prevent a medication gap, with earlier contact for urgent needs.
• Insurance in place before the door opens — Medicaid re-activated (not just re-applied for), Ryan White eligibility confirmed, and ADAP enrollment started.
• A warm handoff: the inside clinician talks to the outside clinician, ideally by phone or in a shared record, before the transfer¹².
• A housing plan. If housing is not stable, connect the person to housing case management (HOPWA in Florida) before release — not after.
• Contact information for a peer navigator or reentry coach — someone who has been through it and can be reached that first week.
• A written medical summary the person can carry: current regimen, last viral load and CD4, resistance history, allergies, and any co-conditions (hep C, mental health, substance use).

Race, mass incarceration, and HIV

Racial disparities in incarceration overlap with disparities in HIV burden and access to care. These patterns require attention to equitable testing, treatment, release planning, and community services; they should not be reduced to one undated national ratio.

The result: mass incarceration amplifies and perpetuates HIV disparities in Black and Latino communities. Every time a person is cycled through the criminal justice system with interrupted HIV care, the damage extends beyond that individual — to their sexual partners, their family networks, their communities. The racial injustice of mass incarceration and the racial injustice of the HIV epidemic are not separate problems.

Addressing HIV in correctional settings is, among other things, a racial justice issue. Decarceration — reducing the number of people incarcerated, particularly for low-level drug offenses — would have direct public health benefits for HIV outcomes in Black and Latino communities.

Trans and gender-nonconforming people in custody

Transgender women — particularly Black and Latina trans women — are dramatically over-represented in the U.S. HIV epidemic and in the U.S. carceral system. Human Rights Watch’s 2018 South Florida report cited earlier research reporting that roughly one in five trans women in the U.S. has been incarcerated, and that the rate among Black trans women is about three times higher than among white trans women, with some studies finding a lifetime incarceration rate approaching half of all Black trans women¹³.

Inside, the combination of housing placement (trans women are still often housed in men's facilities), inadequate access to gender-affirming care, and elevated risk of sexual violence stacks harm on top of harm — including HIV acquisition risk¹³. Continuity of both hormone therapy and ART on release is often broken at the same time.

Florida In Focus

BJS reports state-specific prison HIV counts, including Florida, for 2023. For an individual release, the immediate priorities are medication continuity, records, a community appointment, and benefits coordination.

Florida's HIV criminalization laws create a specific added burden for incarcerated people living with HIV: a person can face enhanced criminal charges related to HIV regardless of viral suppression, adding legal complexity to an already difficult situation¹⁴. Incarcerated Floridians living with HIV navigate both their care and potential legal consequences at the same time. (For the state law itself, see our Florida HIV criminalization guide.)

Florida Medicaid eligibility, ADAP enrollment, housing, and transport can all affect continuity after release. Verify current state and facility services instead of assuming an old waiver-status list remains accurate.

AIDS service organizations in Florida's major cities — Miami, Tampa, Orlando, Jacksonville, Fort Lauderdale — often have specific re-entry programming or can connect formerly incarcerated people living with HIV with services. Use our care locator to find help.

Rights and advocacy

Legal rights of incarcerated people living with HIV

Incarcerated people have legal protections concerning serious medical needs. Report delays or denials to the medical team and available grievance channels, keep records, and seek legal assistance when needed. A person’s legal status and jurisdiction affect the applicable standard.6

Confidentiality

HIV information has privacy protections, but HIPAA permits certain disclosures for correctional health, safety, and security needs. It is not an absolute secrecy rule. Ask a legal advocate to review suspected improper sharing.^[17]

Advocacy organizations

Organizations working at the HIV-incarceration intersection include the Center for HIV Law and Policy, the ACLU's National Prison Project, the Positive Women's Network, and local AIDS service organizations with re-entry programs. HIV advocacy that doesn't include correctional settings is incomplete advocacy.